Researchers reviewed 26 human studies on cannabinoids for skin conditions and found promising results for inflammatory disorders like systemic sclerosis, dermatomyositis, and epidermolysis bullosa pain. However, the evidence is still early-stage—most studies were small, and researchers explicitly say more work is needed on dosing, safety, and long-term effects before CBD becomes standard treatment.

Scientists searched medical databases for human studies on cannabinoids and skin from 1965 to October 2020, then analyzed 26 that met their criteria (they excluded animal studies and review articles to focus on actual evidence).

Funding not disclosed in abstract